Neion Bio Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
24
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$23M
- Investors
-
10
Neion Bio General Information
Description
Developer of a biomanufacturing platform designed to produce biological medicines using re-engineered protein systems. The company offers genetically engineered egg-based bioreactors and advanced genome engineering techniques, enabling biopharmaceutical and animal health companies to manufacture biological molecules with improved scalability, consistency, and cost efficiency.
Contact Information
Website
www.neionbio.comCorporate Office
- Ford Center Incubator
- 1230 York Avenue
- New York, NY 10065
- United States
Corporate Office
- Ford Center Incubator
- 1230 York Avenue
- New York, NY 10065
- United States
Neion Bio Timeline
Neion Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 11-Jun-2026 | $23M | Completed | Generating Revenue | ||
| 1. Seed Round | 27-Mar-2026 | Completed | Stealth |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Neion Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Neion Bio Patents
Neion Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026102400-A1 | Methods for generation of transgenic birds for producing recombinant proteins | Pending | 08-Nov-2024 |
Neion Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Neion Bio Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Also Capital | Venture Capital | Minority | ||
| Clocktower Ventures | Venture Capital | Minority | ||
| Digitalis Ventures | Venture Capital | Minority | ||
| Ensemble VC | Venture Capital | Minority | ||
| Hawktail | Venture Capital | Minority |
Neion Bio FAQs
-
When was Neion Bio founded?
Neion Bio was founded in 2024.
-
Where is Neion Bio headquartered?
Neion Bio is headquartered in New York, NY.
-
What is the size of Neion Bio?
Neion Bio has 24 total employees.
-
What industry is Neion Bio in?
Neion Bio’s primary industry is Biotechnology.
-
Is Neion Bio a private or public company?
Neion Bio is a Private company.
-
What is Neion Bio’s current revenue?
The current revenue for Neion Bio is .
-
How much funding has Neion Bio raised over time?
Neion Bio has raised $34M.
-
Who are Neion Bio’s investors?
Also Capital, Clocktower Ventures, Digitalis Ventures, Ensemble VC, and Hawktail are 5 of 10 investors who have invested in Neion Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
